{
    "Trade/Device Name(s)": [
        "Arkray SPOTCHEM II LDH test",
        "Arkray SPOTCHEM I LDH test"
    ],
    "Submitter Information": "Arkray, Inc.",
    "510(k) Number": "K050790",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CFH"
    ],
    "Summary Letter Date": "August 12, 2013",
    "Summary Letter Received Date": "",
    "Submission Date": "March 18, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1440"
    ],
    "Regulation Name(s)": [
        "Lactate dehydrogenase test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Lactate dehydrogenase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [],
    "Document Summary": "FDA 510(k) summary for Arkray SPOTCHEM LDH test for measurement of lactate dehydrogenase activity",
    "Indications for Use Summary": "Intended to measure lactate dehydrogenase activity in serum, plasma, and whole blood for diagnosis and treatment of liver diseases, cardiac diseases, and tumors of lung or kidneys",
    "fda_folder": "Clinical Chemistry"
}